Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine for myocardial protection during intermittent warm blood cardioplegia in minimally invasive mitral valve surgery
2015-001923-22Phase 4Completed
- Sponsor
- Amphia Ziekenhuis
- Start
- Nov 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of adenosine in Myocardial injury (2 arms), sponsored by Amphia Ziekenhuis. Primary endpoint: Postoperative 6-hour cardiac troponin T release. Started Nov 2015; status: completed.
02
Drugs
adenosine
03
Conditions
Myocardial injury
Beyond the preview
Go deeper on 2015-001923-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001923-22.